Enhanced chemodynamic therapy and immunotherapy by hypoxia augmentation for tumor ablation
Authors:
- Ruiting YuanRYRuiting Yuan
- Yan LiYLYan Li
- Zhenhua WangZWZhenhua Wang
- Lianghao JiaLJLianghao Jia
- Xing GuoXGXing Guo
- Shaobing ZhouSZShaobing Zhou
- 15 June 2023
- journal article
- research article
- Published by Elsevier in Nano Today
- Vol. 51
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell deathNature Communications, 2015
- Direct Precipitation for a Continuous Synthesis of Nanoiron Phosphate with High PurityIndustrial & Engineering Chemistry Research, 2014
- Influence of tumour micro-environment heterogeneity on therapeutic responseNature, 2013
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapyProceedings of the National Academy of Sciences, 2012
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nature Reviews Drug Discovery, 2009
- Surface Modification of Pharmaceutical Nanocarriers with Ascorbate Residues Improves their Tumor-Cell Association and Killing and the Cytotoxic Action of Encapsulated Paclitaxel In VitroPharmaceutical Research, 2008
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- The biochemistry of apoptosisNature, 2000
- Angiogenesis in cancer and other diseasesNature, 2000